Supreme Pharmaceuticals Inc. — Form D
Supreme Pharmaceuticals Inc. of Toronto, A6, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-17. The offering totals $370K, of which $370K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-03-17
- Form: D
- Accession: 0001622240-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $370K
- Amount sold: $370K
- Investors: 1
- Date of first sale: 2016-12-13
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-282836
Issuer
- Name: Supreme Pharmaceuticals Inc.
- CIK: 0001622240
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 202 - 20 De Boers Drive, Toronto, A6, M3J 0H1
- Phone: 647-525-5463
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Navdeep Dhaliwal | Director | Toronto, A6 |
| John Fowler | Director | Amaranth, A6 |
| Michael La Brier | Director | Toronto, A6 |
| CHUCK RIFICI | Director | SEATTLE, WA |
| Scott Walters | Director | Toronto, A6 |
| Navdeep Dhaliwal | Executive Officer | Toronto, A6 |
| John Fowler | Executive Officer | Amaranth, A6 |
| David Stadnyk | Director | Vancouver, A1 |
| David Stadnyk | Executive Officer | Vancouver, A1 |
| Chris Bechtel | Director | Boulder, CO |
| George Tsafalas | Director | Vancouver, A1 |
| Tatiana Kovaleva | Executive Officer | Vancouver, A1 |
| Cailin Gehlsen | Executive Officer | Toronto, A6 |
| Allan Levien | Director | Toronto, A6 |
| Christopher Bechtel | Director | Toronto, A6 |
| Peter Herburger | Executive Officer | Toronto, A6 |
Other filings by this issuer (5)
More